Abstract:Background: Heart failure, which is a major global health problem, is often preceded by pathological cardiac hypertrophy. The expansion of the cardiac vasculature, to maintain adequate supply of oxygen and nutrients, is a key determinant of whether the heart grows in a physiological compensated manner or a pathological decompensated manner. Bidirectional endothelial cell (EC)-cardiomyocyte (CMC) cross talk via cardiokine and angiocrine signaling plays an essential role in the regulation of cardiac growth and homeostasis. Currently, the mechanisms involved in the EC-CMC interaction are not fully understood, and very little is known about the EC-derived signals involved. Understanding how an excess of angiogenesis induces cardiac hypertrophy and how ECs regulate CMC homeostasis could provide novel therapeutic targets for heart failure. Methods: Genetic mouse models were used to delete vascular endothelial growth factor (VEGF) receptors, adeno-associated viral vectors to transduce the myocardium, and pharmacological inhibitors to block VEGF and ErbB signaling in vivo. Cell culture experiments were used for mechanistic studies, and quantitative polymerase chain reaction, microarrays, ELISA, and immunohistochemistry were used to analyze the cardiac phenotypes. Results: Both EC deletion of VEGF receptor (VEGFR)-1 and adeno-associated viral vector-mediated delivery of the VEGFR1-specific ligands VEGF-B or placental growth factor into the myocardium increased the coronary vasculature and induced CMC hypertrophy in adult mice. The resulting cardiac hypertrophy was physiological, as indicated by preserved cardiac function and exercise capacity and lack of pathological gene activation. These changes were mediated by increased VEGF signaling via endothelial VEGFR2, because the effects of VEGF-B and placental growth factor on both angiogenesis and CMC growth were fully inhibited by treatment with antibodies blocking VEGFR2 or by endothelial deletion of VEGFR2. To identify activated pathways downstream of VEGFR2, whole-genome transcriptomics and secretome analyses were performed, and the Notch and ErbB pathways were shown to be involved in transducing signals for EC-CMC cross talk in response to angiogenesis. Pharmacological or genetic blocking of ErbB signaling also inhibited part of the VEGF-B-induced effects in the heart. Conclusions: This study reveals that cross talk between the EC VEGFR2 and CMC ErbB signaling pathways coordinates CMC hypertrophy with angiogenesis, contributing to physiological cardiac growth.

Regulation of Vasculogenesis and Angiogenesis by EphB/ephrin-B2 Signaling Between Endothelial Cells and Surrounding Mesenchymal Cells

Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy with Its Homologue TIE2

Essential Roles of EphrinB2 in Mammalian Heart: from Development to Diseases.

Eph-ephrin signaling couples endothelial cell sorting and arterial specification

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Regulation of signaling interactions and receptor endocytosis in growing blood vessels

Stromal Cells Expressing Ephrin-B2 Promote the Growth and Sprouting of Ephrin-B2+ Endothelial Cells

EphrinB2/EphB4 Pathway in Postnatal Angiogenesis: a Potential Therapeutic Target for Ischemic Cardiovascular Disease

EphrinB2 controls vessel pruning through STAT1-JNK3 signalling

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding

Eph Receptors and Ephrins in Tumorigenesis

Ephrin-B2/Fc Promotes Proliferation and Migration, and Suppresses Apoptosis in Human Umbilical Vein Endothelial Cells.

Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy

Abstract TP2: Increase of EphrinB2/EphB4 Signaling Reduces the Severity of Brain Arteriovenous Malformation in Endoglin Deficient Mice Through Reduction of Angiogenesis and Inflammation

E-Prostanoid 3 Receptor Mediates Sprouting Angiogenesis Through Suppression of the Protein Kinase A/β-Catenin/Notch Pathway

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration

Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling

Vascular Development is Disrupted by Endothelial Cell-Specific Expression of the Anti-Apoptotic Protein Bcl-2

Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system